Valeant Pharmaceuticals International (BHC) Earnings
|
Expand Research on BHC
| Next EPS Date | 10/29/26 | EPS Growth Rate | +158.3% |
|---|---|---|---|
| Average EPS % Beat Rate | -35.4% | Revenue Growth Rate | +2.2% |
| Average % Move 1-Wk after EPS | +8.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/29/26  |
Q326 | N/A | $1.24 | N/A | N/A | $2.74B | = | N/A | N/A | ||
| 7/29/26 | Q226 | $1.26 | $1.03 | +$0.23 | $2.85B | $2.66B | = |  | | Details | |
| 4/29/26 | Q126 | $0.78 | $0.68 | +$0.10 | $2.52B | $2.42B | = | | | Details | |
| 2/18/26 | Q425 | -$0.30 | $1.21 | -$1.51 | $2.8B | $2.71B | = | | | Details | |
| 10/29/25 |
Q325 | $0.48 | $1.04 | -$0.56 | $2.68B | $2.61B | = | | | Details | |
| 7/30/25 | Q225 | $0.40 | $0.04 | +$0.36 | $2.53B | $2.48B | = | | | Details | |
| 4/30/25 |
Q125 | N/A | $0.87 | N/A | N/A | $2.29B | = | N/A | N/A | ||
| 2/19/25 |
Q424 | $0.25 | $0.23 | +$0.02 | $2.56B | $2.52B | = | | | Details |
